Breast cancer following augmentation mammaplasty with polyacrylamide hydrogel (PAAG) injection.
Polyacrylamide hydrogel (PAAG) as an implanted material for augmentation mammaplasty has been used for years in China. Many kinds of complications associated with PAAG use have been reported in the clinical literature. This report presents two cases of breast cancer occurring after injection of PAAG in augmented breasts. The delayed diagnosis and more aggressive disease due to PAAG injection should be cause for concern. It is very important to detect breast cancer early when it is covered by the induration of the injected gel and inflammation reaction after PAAG injection. PAAG injection for augmentation mammaplasty may affect the outcome of breast cancer diagnosis and prognosis.
Cheng
Ning-Xin
NX
Department of Plastic and Aesthetic Surgery, The First Affiliated Hospital, Guangdong Pharmaceutical University, No. 19 Longlinxialu, Guanzhou, 510080, China. chengningxin@163.net
Liu
Li-Gang
LG
Hui
Li
L
Chen
Yuan-Liang
YL
Xu
Shi-Liang
SL
D000180:Acrylic Resins / Q000008:administration & dosage* / Q000009:adverse effects*; D000328:Adult; D001943:Breast Neoplasms / Q000139:chemically induced*; D005260:Female; D005782:Gels / Q000008:administration & dosage* / Q000009:adverse effects*; D006801:Humans; D007267:Injections; D016462:Mammaplasty / Q000379:methods*
D000180:Acrylic Resins; D005782:Gels; C016680:polyacrylamide gels